Rubeola (Measles) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Rubeola, more commonly known as measles, is an acute viral respiratory illness caused by the measles virus, a member of the Paramyxoviridae family. The disease is highly contagious and spreads through respiratory droplets or direct contact with nasal or throat secretions of an infected person.

Who it affects: While measles can infect anyone who is not immune, it is most common in children under 5 years of age. However, outbreaks frequently involve adolescents and adults who missed vaccination or whose immunity has waned.

Global prevalence: Before the introduction of the measles vaccine in the 1960s, the disease caused an estimated 2.6 million deaths each year worldwide. Thanks to vaccination, global deaths dropped to about 140,000 in 2018. Nevertheless, measles remains a leading cause of vaccine‑preventable deaths; in 2022 the World Health Organization reported > 600,000 deaths, largely in low‑income countries where vaccine coverage is sub‑optimal.

Symptoms

Measles typically follows a predictable pattern, appearing in three phases: prodromal (early), rash, and convalescent.

Prodromal (early) symptoms (2‑4 days)

• Fever – often > 40 °C (104 °F) and may last 4–7 days.
• Koplik spots – tiny white or bluish lesions with a red halo on the buccal mucosa, considered pathognomonic.
• Cough – dry, persistent.
• Coryza (runny nose) and conjunctivitis (red, watery eyes).
• General malaise, headache, and loss of appetite.

Rash phase (days 4‑6)

• Maculopapular rash that usually starts on the hairline and spreads downward to the face, neck, trunk, arms, and legs.
• Rash may coalesce, giving a “brick‑red” appearance.
• It typically lasts 5–6 days before fading, often leaving temporary hyperpigmentation.

Other possible manifestations

• Ear infections (otitis media)
• Diarrhea
• Encephalitis (rare, ~1 in 1,000 cases)
• Subacute sclerosing panencephalitis (SSPE) – a progressive, fatal brain disease that can appear years after infection.

Causes and Risk Factors

Cause

Measles is caused by the measles virus (MeV). The virus attaches to the CD150 (SLAM) receptor on immune cells, replicates in the respiratory tract, and then spreads systemically. The incubation period averages 10‑14 days.

Risk factors

• Unvaccinated status – the single most important risk factor.
• Travel to regions with low vaccination coverage (e.g., parts of Sub‑Saharan Africa, South‑East Asia).
• Living in crowded settings such as schools, refugee camps, or prisons.
• Immunocompromised conditions (e.g., HIV, cancers, organ transplant recipients).
• Pregnancy – pregnant women are at higher risk for severe disease and complications.

Diagnosis

Diagnosis is primarily clinical, supported by laboratory testing.

Clinical assessment

• History of exposure or travel to an outbreak area.
• Presence of Koplik spots and characteristic rash.
• Fever ≥ 38 °C with cough, coryza, and conjunctivitis.

Laboratory tests

• Serology: Detection of measles‑specific IgM antibodies in serum (positive 3‑5 days after rash onset). IgG seroconversion confirms past infection or successful vaccination.
• Polymerase chain reaction (PCR): Real‑time RT‑PCR on throat swab, nasopharyngeal aspirate, or urine provides rapid confirmation, especially useful in immunocompromised patients.
• Viral culture: Rarely performed; requires biosafety level‑2 labs.

Treatment Options

There is no specific antiviral cure for measles; treatment is supportive and aims to prevent complications.

Medications

• Vitamin A supplementation – WHO recommends 200,000 IU oral vitamin A for children ≥ 1 year old (repeat next day). It reduces morbidity and mortality, especially in malnourished children.
• Antipyretics – Acetaminophen or ibuprofen for fever and pain. Aspirin should be avoided because of the risk of Reye’s syndrome.
• Antibiotics – Only if bacterial superinfection (e.g., otitis media, pneumonia) is diagnosed.

Procedures & supportive care

• Hydration (oral or intravenous) to prevent dehydration from fever and diarrhea.
• Isolation in a single‑room with airborne precautions (negative pressure if available) for at least 4 days after rash onset.
• Oxygen therapy for severe respiratory compromise.

Lifestyle / home measures

• Rest and a light diet.
• Cool compresses to relieve fever.
• Maintain good hand hygiene to limit spread to family members.

Living with Rubeola (Measles)

While most people recover fully, the illness can be exhausting. Below are practical tips for patients and caregivers.

• Hydration: Aim for 8‑10 glasses of fluid daily; oral rehydration solutions are helpful if vomiting.
• Nutrition: Offer small, frequent meals rich in vitamins A, C, and zinc (e.g., fruit, leafy greens, beans).
• Fever control: Use acetaminophen every 4‑6 hours, not exceeding 4 g per day for adults.
• Monitor rash: Keep fingernails trimmed to prevent skin infections from scratching.
• Separate sleeping areas for the infected individual if possible, especially from infants, pregnant women, or immunocompromised household members.
• Follow‑up: Schedule a visit with your primary‑care provider 1–2 weeks after recovery to confirm immunity (IgG) and discuss any lingering complications.

Prevention

Vaccination

The cornerstone of measles control is the MMR vaccine (measles‑mumps‑rubella). The US CDC recommends two doses:

• First dose at 12‑15 months of age.
• Second dose at 4‑6 years (or earlier if travel risk exists).

Two doses confer ~97 % effectiveness; a single dose provides ~93 % protection.

Additional preventive measures

• Herd immunity: Maintaining ≥ 95 % coverage in the community prevents outbreaks.
• Airborne precautions in healthcare settings (N95 respirators, negative‑pressure rooms).
• Post‑exposure prophylaxis (PEP): Unvaccinated individuals exposed to measles should receive MMR within 72 hours or immune globulin (IG) ≤ 6 days post‑exposure if vaccine is contraindicated.
• Travelers should verify vaccination status at least 14 days before departure to endemic areas.

Complications

Most children recover without sequelae, yet measles can cause serious, sometimes fatal, complications:

• Pneumonia – leading cause of measles‑related death.
• Acute otitis media – can cause temporary hearing loss.
• Encephalitis – occurs in ~1/1,000 cases, with a 10‑20 % mortality rate.
• Subacute sclerosing panencephalitis (SSPE) – a progressive neurodegenerative disease manifesting 5‑15 years after infection.
• Diarrhea and severe dehydration, especially in malnourished children.
• Pregnancy complications: Increased risk of miscarriage, preterm labor, and low birth‑weight infants.

When to Seek Emergency Care

Early recognition and supportive care dramatically improve outcomes.

---

References

• Mayo Clinic. Measles (Rubeola) – Symptoms & Causes. Accessed 30 Apr 2026.
• World Health Organization. Measles Fact Sheet. Updated 2022.
• Centers for Disease Control and Prevention. Measles — Clinical Care. 2024.
• Cleveland Clinic. Measles (Rubeola). 2023.
• National Institutes of Health, National Library of Medicine. Measles complications: a systematic review. 2023.

```